Neuroimmune appendicitis, peptides, and schizophrenia [9]

Lancet

Volumn 354, Issue 9190, 1999, Pages 1648-

  Lauerma, H ^a  

^a Mental Hospital for Prisoners   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPEPTIDE; PEPTIDE; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ABDOMINAL PAIN; APPENDICITIS; BRAIN CORTEX; COMORBIDITY; COMPARATIVE STUDY; DOPAMINERGIC ACTIVITY; FINLAND; HUMAN; LETTER; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; NEUROIMMUNOLOGY; PERIPHERAL CIRCULATION; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; SCHIZOPHRENIA;

EID: 0033530370     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)77136-1     Document Type: Letter

References (5)

1. P Di Sebastiano T Fink FF di Mola Neuroimmune appendicitis Lancet 354 1999 461 466
2. G Panza E Monzani P Sacerdote G Penati AE Panerai Beta-endorphin, vasoactive intestinal peptide and cholecystokinin in peripheral blood mononuclear cells from healthy subjects and from drug-free and haloperidol-treated schizophrenic patients Acta Psychiatr Scand 85 1992 207 210
3. SM Gabriel M Davidson V Haroutunian Neuropeptide deficits in schizophrenia vs Alzheimer's disease cerebral cortex Biol Psychiatr 39 1996 82 91
4. H Lauerma V Lehtinen M Joukamaa M-R Järvelin H Helenius M Isohanni Schizophrenia among patients treated for rheumatoid arthritis and appendicitis Schizophr Res 29 1998 255 261
5. WW Eaton C Hayward R Ram Schizophrenia and rheumatoid arthritis: a review Schizophr Res 6 1992 181 192